We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

150 hedge funds and large institutions have $827M invested in PharMerica Corporation in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more call options, than puts

Call options by funds: $24K | Put options by funds: $2K

9% more capital invested

Capital invested by funds: $756M → $827M (+$71.1M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 45

4% less funds holding

Funds holding: 157150 (-7)

11% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 37

Holders
150
Holders Change
-7
Holders Change %
-4.46%
% of All Funds
3.74%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
45
Reduced
45
Closed
37
Calls
$24K
Puts
$2K
Net Calls
+$22K
Net Calls Change
-$419K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$117M +$2M +71,352 +2%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$76.5M -$243K -8,674 -0.3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$50.8M +$2.36M +84,254 +5%
WIC
4
Water Island Capital
New York
$42.8M +$40.9M +1,460,861 New
Boston Partners
5
Boston Partners
Massachusetts
$42.1M +$1.69M +60,232 +4%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$32.9M -$597K -21,330 -2%
Fuller & Thaler Asset Management
7
Fuller & Thaler Asset Management
California
$28.3M +$36.5K +1,302 +0.1%
Deutsche Bank
8
Deutsche Bank
Germany
$28.3M +$13.7M +488,030 +102%
State Street
9
State Street
Massachusetts
$23.4M -$244K -8,723 -1%
N
10
Nuveen
North Carolina
$20M -$11M -393,490 -37%
PP
11
Prudential plc
United Kingdom
$16.8M +$2.92M +104,100 +22%
UBS Group
12
UBS Group
Switzerland
$15.5M +$12.1M +431,618 +441%
Northern Trust
13
Northern Trust
Illinois
$12.8M -$119K -4,231 -1%
JP Morgan Chase
14
JP Morgan Chase
New York
$12.5M +$5.27M +188,163 +79%
Goldman Sachs
15
Goldman Sachs
New York
$12.3M +$10.6M +379,197 +919%
Allianz Asset Management
16
Allianz Asset Management
Germany
$11.7M +$10.9M +388,000 +3,347%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$11.6M -$34.2K -1,222 -0.3%
LSV Asset Management
18
LSV Asset Management
Illinois
$11M -$2.88M -102,910 -22%
AA
19
AQR Arbitrage
Connecticut
$10.3M +$9.8M +350,000 New
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$9.57M -$1.3M -46,585 -12%
Ameriprise
21
Ameriprise
Minnesota
$8.84M -$2.6M -92,795 -24%
SG Americas Securities
22
SG Americas Securities
New York
$8.23M +$7.67M +273,801 +3,800%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$8.23M -$2.81M -100,479 -26%
Charles Schwab
24
Charles Schwab
California
$7.9M +$108K +3,864 +1%
SBH
25
Segall Bryant & Hamill
Illinois
$7.85M -$324K -11,549 -4%

PMC Hedge Fund Activity: Q3 2017 in Review

150 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q3 2017, worth a combined $827M — up 9.4% from $756M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of PMC and 33 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 45 added.

The largest buyer was Water Island Capital, opening a new position worth an estimated $40.9M. The largest seller was Victory Capital Management, exiting entirely with an estimated $34M sold.

  • 150 institutional investors held PharMerica Corporation (PMC) as of Q3 2017, down from 157 in Q2 2017.
  • Funds reported $827M of PharMerica Corporation stock for Q3 2017, up 9.4% quarter-over-quarter.
  • 33 funds opened new PharMerica Corporation positions in Q3 2017 and 37 closed out, a net change of -4 holders.
  • The largest PharMerica Corporation buyer in Q3 2017 was Water Island Capital, an estimated $40.9M added.
  • The largest PharMerica Corporation seller in Q3 2017 was Victory Capital Management, an estimated $34M sold.

Based on aggregated 13F filings for Q3 2017.